Disorderly DNA Helps Cancer Cells Evade Treatment
A new Northwestern University study has discovered that the packing of the three-dimensional genome structure, called chromatin, controls how cells respond to stress.
Browsing: "Cancer"
AI Model Improves Breast Cancer Detection
An AI model predicted breast cancer in mammograms more accurately than radiologists, reducing false positives and false negatives, according to a new study.
2019 in Scientific Images
These images illustrate the physical reality Northwestern scientists work within, striving to uncover the mysteries of biology, chemistry and medicine.
Nanoparticle Drug Delivery Could Boost Cancer Therapy
A new lipid nanoparticle drug helped make tumor cells more vulnerable to therapy, significantly prolonging survival in models of glioblastoma.
Protein Protects Nucleus from Rupture
A cytoskeletal protein called vimentin helps prevent the nuclei of cells that must navigate through tight spaces in the body from rupturing, according to a recent study.
Dangerous Skin Tumor Now Has Treatment Guidelines
A Northwestern Medicine study reports the first guidelines for treating sebaceous carcinoma, a cancer of the oil glands diagnosed in thousands of patients every year.
Hidden Data in ‘Junk DNA’ May Predict Cancer
A new machine-learning tool demonstrates the clinical potential of ‘junk DNA’ methylation in hepatitis C-associated liver cancer patients without the need for expensive testing.
Combination Treatment Beats Chemotherapy in Breast Cancer
A new review has found that a combination of endocrine inhibitors and hormone therapy is more effective in prolonging progression-free survival for advanced breast cancer patients, as compared to chemotherapy.
New Molecule Blocks ‘Undruggable’ Cancer Protein
Northwestern Medicine scientists have created a small molecule that reduces expression of MYC, a cancer-causing protein involved in a wide variety of cancers.
Overexpression of Enzyme Increases Risk of Treatment Failure in Breast Cancer
The overexpression of mitochondrial superoxide dismutase, commonly found in late-stage tumors, may drive cancer stem cell formation and contribute to the failure of chemotherapy treatment in breast cancer patients.